e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 27, 2005
Cholestech Corporation
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| California
|
|
000-20198
|
|
94-3065493 |
|
|
|
|
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.) |
3347 Investment Boulevard
Hayward, California 94545
(Address of principal executive offices, including zip code)
(510) 732-7200
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition
On July 27, 2005, Cholestech Corporation (“Cholestech”) is issuing a press release and holding
a conference call regarding its financial results for the first quarter ended June 24, 2005. A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated by reference.
The information in this Current Report on Form 8-K and the exhibit attached hereto shall not
be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any
general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits
(c) Exhibits
| |
|
|
Exhibit No.
|
|
Description |
|
|
|
99.1
|
|
Press Release of Cholestech Corporation dated July 27, 2005 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
CHOLESTECH CORPORATION
|
|
| Date: July 27, 2005 |
By: |
/s/ John F. Glenn
|
|
| |
|
John F. Glenn |
|
| |
|
Vice President of Finance and Chief Financial Officer |
|
| |
EXHIBIT INDEX
| |
|
|
Exhibit No.
|
|
Description |
|
|
|
99.1
|
|
Press Release of Cholestech Corporation dated July 27, 2005 |